Home/Filings/4/0000884905-14-000008
4//SEC Filing

PRAXAIR INC 4

Accession 0000884905-14-000008

CIK 0000884905operating

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 3:47 PM ET

Size

18.3 KB

Accession

0000884905-14-000008

Insider Transaction Report

Form 4
Period: 2014-02-18
Breedlove James T
Senior VP, Gen. Counsel & Sec.
Transactions
  • Sale

    Common Stock

    2014-02-18$129.83/sh40,000$5,193,20033,614 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-02-1840,0004,120 total
    Exercise: $60.92From: 2010-02-24Exp: 2019-02-24Common Stock (40,000 underlying)
  • Exercise/Conversion

    Common Stock

    2014-02-18$60.92/sh+40,000$2,436,80073,614 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    5,237.424
  • Stock Option (right to buy)

    Exercise: $83.89From: 2009-02-26Exp: 2018-02-26Common Stock (39,300 underlying)
    39,300
  • Stock Option (right to buy)

    Exercise: $76.16From: 2011-02-23Exp: 2020-02-23Common Stock (34,960 underlying)
    34,960
  • Stock Option (right to buy)

    Exercise: $97.84From: 2012-02-22Exp: 2021-02-22Common Stock (37,930 underlying)
    37,930
  • Stock Option (right to buy)

    Exercise: $109.68From: 2013-02-28Exp: 2022-02-28Common Stock (36,095 underlying)
    36,095
  • Stock Option (right to buy)

    Exercise: $110.58From: 2014-02-26Exp: 2023-02-26Common Stock (29,755 underlying)
    29,755
  • Deferred Stock

    Exercise: $0.00Common Stock (1,259.54 underlying)
    1,259.54
Footnotes (7)
  • [F1]The $129.83 price reported is the weighted average sale price. The sale prices ranged from $129.47 to $130.178 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
  • [F2]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
  • [F3]This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
  • [F4]This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
  • [F5]This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
  • [F6]Conversion to Praxair Common Stock is on a 1-for-1 basis.
  • [F7]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferral Program") and are to be settled in Praxair Common Stock.

Issuer

PRAXAIR INC

CIK 0000884905

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000884905

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 3:47 PM ET
Size
18.3 KB